Invention Grant
- Patent Title: Method and composition for administering an NMDA receptor antagonist to a subject
-
Application No.: US12512701Application Date: 2009-07-30
-
Publication No.: US08168209B2Publication Date: 2012-05-01
- Inventor: Gregory T. Went , Timothy J. Fultz , Seth Porter , Laurence R. Meyerson , Timothy S. Burkoth
- Applicant: Gregory T. Went , Timothy J. Fultz , Seth Porter , Laurence R. Meyerson , Timothy S. Burkoth
- Applicant Address: US CA Emeryville
- Assignee: Adamas Pharmaceuticals, Inc.
- Current Assignee: Adamas Pharmaceuticals, Inc.
- Current Assignee Address: US CA Emeryville
- Agency: Wilson, Sonsini, Goodrich & Rosati
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/17 ; A61K27/00 ; A01N47/28 ; A01N31/15
Abstract:
The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.
Public/Granted literature
- US20100047342A1 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject Public/Granted day:2010-02-25
Information query
